Arvinas (ARVN)
(Delayed Data from NSDQ)
$25.05 USD
+0.54 (2.20%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $25.07 +0.02 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Brokerage Reports
Arvinas, Inc. [ARVN]
Reports for Purchase
Showing records 141 - 160 ( 213 total )
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Reiterating Buy Ahead of 4Q20 Data Readout - $65 Price Target
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Register For Week-1 of Our Management Talk Series With IVA, RAPT, KALV - AGTC
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Next Week We''ll Kick Off Our Management Talk Series
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Upcoming Webinars to Discuss Near-Term Catalysts with Our Covered Companies
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
2Q20 Update: Strong Cash Position with Exciting Catalysts Before YE2020
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Thoughts Ahead of ARV-471 Data Readout in 4Q20; Reit Buy and $60 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Q2 Financials; Two Key Clinical Data Updates Expected in Q4
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
ASCO Data Represents a Better-Case Scenario in Our Mind
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arvinas, Inc.
Industry: Medical - Biomedical and Genetics
ARV-110 ASCO Presentation: ?110 Working as Designed
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department